Arteriovenous Malformation of Central Nervous System

2

Review clinical trials related to Arteriovenous Malformation of Central Nervous System. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM

AVMs have been reported to rupture at a formidable annual rate of 2% to 3% at natural progression, often resulting in longterm neurological deficits and poor functional outcomes.The reported risk of hemorrhagic presentation in patients with AVMs is 41% to 65%. While many studies suggest a correlation between higher hemorrhage risk and the concurrent presence of AVM and aneurysms, few authors have focused specifically on flow-related aneurysms alone. In many instances, the source of rupture is also unclear. Meta-analysis from 2016 suggested that 49.2% of hemorrhages were secondary to aneurysm rupture, 45% from AVM rupture, and 5.7% were undetermined.In a study of 302 patients, of which 52.6% had a hemorrhagic presentation, demonstrated a significant increase in rate of hemorrhage in those with flow-related aneurysms. Thus, it is necessary to figure out risk factors related to ruptured flow-related aneurysms in pAVM.

Participants needed: 200
Trial details
Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital with Nanjing Medical UniversityUpdated: Jul 3, 2025Locations: 2
Eligibility criteria

pAVM with flow-related aneurysms were identified by DSA, and subarachnoid hemorr... [+1]

pAVM without flow-related aneurysms [+1]

Status: Recruiting

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Participants needed: 50,000
Trial details
Biological sex: AllType: ObservationalSponsor: The Radiosurgery SocietyUpdated: Sep 19, 2024Locations: 13Duration: 20 Years
Eligibility criteria

Diagnosis of benign or malignant tumors or other conditions deemed treatable by... [+1]

There are no specific exclusion criteria, but patients who are unwilling to sign...